Skip to main content

LIDOCAINE HCI AND EPINEPHRINE

NDC 51662-1395 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameLIDOCAINE HCI AND EPINEPHRINE
Dosage formINJECTION, SOLUTION
RouteINFILTRATION, PERINEURAL
Active ingredient(s)LIDOCAINE HYDROCHLORIDE, EPINEPHRINE
Strength10; 10 ug/mL; mg/mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

51662-1395-1 — 50 mL in 1 VIAL, MULTI-DOSE (51662-1395-1)

51662-1395-3 — 25 POUCH in 1 CASE (51662-1395-3) / 1 mL in 1 POUCH (51662-1395-2)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51662-1233 — LIDOCAINE HCI, 51662-1290 — ADRENALIN (EPINEPHRINE), 51662-1307 — ADRENALIN(R), 51662-1320 — EPINEPHRINE, 51662-1321 — EPINEPHRINE, 51662-1326 — 2% LIDOCAINE HCI, 51662-1364 — LIDOCAINE HCI, 51662-1382 — LIDOCAINE HCI, 51662-1384 — LIDOCAINE HCI, 51662-1389 — LIDOCAINE HCI, 51662-1416 — LIDOCAINE HCI, 51662-1419 — LIDOCAINE HCI, 51662-1422 — LIDOCAINE HCI, 51662-1438 — LIDOCAINE HCl, 51662-1454 — LIDOCAINE HYDROCHLORIDE, 51662-1461 — LIDOCAINE HCI, 51662-1465 — 1% LIDOCAINE HCI, 51662-1466 — 1% LIDOCAINE HCI, 51662-1467 — 2% LIDOCAINE HCI, 51662-1476 — EPINEPHRINE, +823 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels